Group One Trading
TAK icon

Group One Trading’s Takeda Pharmaceutical TAK Stock Holding History

Group One Trading’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$83.4K Buy
5,200
+1,300
+33% +$21.5K ﹤0.01% 5002
2026
Q1 		$72.2K Sell
3,900
-7,500
-66% -$132K ﹤0.01% 4992
2025
Q4 		$178K Sell
11,400
-14,900
-57% -$213K ﹤0.01% 4483
2025
Q3 		$385K Buy
26,300
+17,300
+192% +$257K ﹤0.01% 3950
2025
Q2 		$139K Buy
9,000
+1,300
+17% +$19.2K ﹤0.01% 4684
2025
Q1 		$114K Buy
7,700
+2,000
+35% +$28K ﹤0.01% 4487
2024
Q4 		$75.5K Sell
5,700
-7,900
-58% -$109K ﹤0.01% 4749
2024
Q3 		$193K Sell
13,600
-6,900
-34% -$97.9K ﹤0.01% 3648
2024
Q2 		$265K Buy
20,500
+18,700
+1,039% +$248K ﹤0.01% 3151
2024
Q1 		$25K Sell
1,800
-284,700
-99% -$4.14M ﹤0.01% 5256
2023
Q4 		$4.09M Sell
286,500
-200
-0.1% -$2.84K 0.01% 1285
2023
Q3 		$4.44M Buy
286,700
+177,400
+162% +$2.75M 0.01% 1014
2023
Q2 		$1.72M Buy
109,300
+93,600
+596% +$1.53M 0.01% 1855
2023
Q1 		$259K Sell
15,700
-47,800
-75% -$761K ﹤0.01% 3428
2022
Q4 		$991K Buy
63,500
+23,900
+60% +$334K ﹤0.01% 2412
2022
Q3 		$514K Buy
39,600
+500
+1% +$6.95K ﹤0.01% 3202
2022
Q2 		$549K Sell
39,100
-273,000
-87% -$3.9M ﹤0.01% 3330
2022
Q1 		$4.47M Sell
312,100
-389,700
-56% -$5.72M ﹤0.01% 1640
2021
Q4 		$9.57M Buy
701,800
+111,300
+19% +$1.56M 0.01% 1142
2021
Q3 		$9.67M Sell
590,500
-203,100
-26% -$3.41M 0.01% 1087
2021
Q2 		$13.4M Sell
793,600
-564,400
-42% -$9.61M 0.02% 876
2021
Q1 		$24.8M Buy
1,358,000
+1,099,000
+424% +$19.8M 0.04% 437
2020
Q4 		$4.71M Buy
259,000
+183,400
+243% +$3.22M 0.01% 1323
2020
Q3 		$1.35M Sell
75,600
-11,700
-13% -$213K ﹤0.01% 1924
2020
Q2 		$1.56M Sell
87,300
-72,800
-45% -$1.31M 0.01% 1647
2020
Q1 		$2.43M Sell
160,100
-111,100
-41% -$2.01M 0.02% 920
2019
Q4 		$5.35M Buy
271,200
+187,200
+223% +$3.58M 0.04% 642
2019
Q3 		$1.45M Buy
84,000
+25,600
+44% +$443K 0.01% 1449
2019
Q2 		$1.03M Buy
58,400
+25,100
+75% +$457K 0.01% 1568
2019
Q1 		$678K Buy
33,300
+8,700
+35% +$175K 0.01% 1705
2018
Q4 		$414K Buy
+24,600
New +$415K ﹤0.01% 2121

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Group One Trading's TAK Position: Q2 2026 in Review

Group One Trading opened a new position in Takeda Pharmaceutical (TAK) in Q2 2026: 34,035 shares worth $546K. The stake represents ﹤0.01% of the portfolio and ranks #3414 among its holdings. This is a return to the name: Group One Trading previously reported a position in TAK as recently as Q2 2025.

Group One Trading first reported a position in TAK in Q1 2019 and has held it in 12 quarters since. The position peaked at $754K in Q2 2022. 378 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • Group One Trading held 34,035 shares of Takeda Pharmaceutical worth $546K as of Q2 2026.
  • Takeda Pharmaceutical was a new Group One Trading position in Q2 2026.
  • Takeda Pharmaceutical made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #3414 holding.
  • Group One Trading first reported a position in Takeda Pharmaceutical in Q1 2019 and has held it in 12 quarters since.
  • Group One Trading's Takeda Pharmaceutical position peaked at $754K in Q2 2022.
  • 378 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.